跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
李 芬瑤
教授
醫學系病理學科
電子郵件
fyli
vghtpe.gov
tw
h-index
h10-index
h5-index
7410
引文
48
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1464
引文
20
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
398
引文
13
h-指數
按照存儲在普爾(Pure)的出版物數量及斯高帕斯(Scopus)引文計算。
1983 …
2024
每年研究成果
概覽
指紋
網路
研究成果
(230)
類似的個人檔案
(6)
指紋
查看啟用 Anna Fen-Yau Li 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Gastric Cancer
76%
Gastric Cancer Patients
45%
Tumor
39%
Curative Surgery
29%
Colorectal Cancer
20%
Taiwan
17%
Microsatellite Instability-high (MSI-H)
17%
Stomach
16%
Genetic Modification
15%
5-year Survival
14%
Overall Survival
14%
Gastric Adenocarcinoma
14%
Clinical Significance
14%
Lymph Node Metastasis
13%
Multivariate Analysis
13%
Chemotherapy
12%
Human Gastric Cancer
11%
Curative Resection
11%
Helicobacter Pylori (H. pylori)
11%
Helicobacter Pylori Infection
11%
Colorectal Cancer Patients
11%
Hepatocellular Carcinoma
10%
Independent Prognostic Factor
10%
Protein Expression
10%
Disease-free Survival
9%
Lymphovascular Invasion
9%
Liver Metastasis
8%
Advanced Gastric Cancer
8%
Gastric Cancer Progression
8%
Poor Prognosis
8%
Liver
8%
Overexpression
8%
Carcinoma
7%
Esophageal Squamous Cell Carcinoma
7%
Gastric Carcinoma
7%
Prognostic Factors
7%
Tumor Recurrence
7%
Prognostic Marker
7%
Taipei
7%
Cyclooxygenase-2
7%
General Hospital
7%
Tyrosine Kinase
7%
Survival Rate
7%
Recurrence Pattern
6%
Robotic Gastrectomy
6%
Hepatocyte Growth Factor
6%
Gastric Tissue
6%
Surgical Outcomes
6%
Pancreas
6%
M1 Cells
6%
Medicine and Dentistry
Abdominal Cancer
100%
Neoplasm
57%
Colorectal Carcinoma
23%
Surgery
20%
Overall Survival
19%
Prognostic Factor
17%
Diseases
17%
Metastatic Carcinoma
17%
Gastrectomy
15%
Malignant Neoplasm
15%
Cancer
14%
Survival Rate
13%
Adenocarcinoma
12%
Recurrent Disease
12%
Gene Mutation
12%
Lymph Node Metastasis
11%
Stomach Adenocarcinoma
11%
Stomach Carcinoma
10%
Multivariate Analysis
10%
Helicobacter Pylori
10%
Esophagus
9%
Protein P53
9%
Disease Free Survival
9%
Microsatellite Instability
9%
Hepatocellular Carcinoma
9%
Squamous Cell Carcinoma
9%
Lymphovascular Invasion
8%
Carcinoma
8%
Small-Cell Carcinoma
7%
Helicobacter Infection
7%
Papanicolaou Stain
6%
Cisplatin
6%
Lymph Node
6%
Protein Expression
6%
Cancer Growth
6%
Biological Marker
6%
Liver Metastasis
6%
Mucinous Carcinoma
6%
Biopsy Technique
5%
Gastrointestinal Tract
5%
Cyclooxygenase 2
5%
Clinical Significance
5%
Adenosquamous Carcinoma
5%